Intrinsiqq
Sam Chun Dang Pharm Co., Ltd. logo

Sam Chun Dang Pharm Co., Ltd. Intrinsic Value

000250.XKRX

Compare

Choose a model

Each card values Sam Chun Dang Pharm Co. a different way, shown at our starting inputs. Pick one to see and change how it works.

Set your assumptions

Sam Chun Dang Pharm Co. on earnings: earnings per share grow for a few years, then the stock trades at a normal price-to-earnings multiple.

Years to project

Growth of earnings per share

Earnings per share; not enough history; starts at 5%

Exit P/E

Starts at its industry's median P/E

Your desired return

Margin of safety

More

Your buy price

The expected return is measured from it; starts at today's price

How it's worked out

  1. Today's earnings per share

    Diluted EPS of ₩864.02 as filed, last twelve months, lowered to what operating profit after tax supports (one-off gains left out)

    ₩523.06

  2. Earnings in 2031

    Grows 5.0% a year for 5 years

    ₩667.57

  3. Price in 2031

    ₩667.57 × 16.7 P/E

    ₩11,148.50

  4. Worth today

    ÷ 1.10^5: your 10% a year, taken back out

    ₩6,922.34

  5. Plus dividends

    ₩290.10 paid over 5 years, discounted the same way

    + ₩217.91

  6. Fair value

    The most you can pay and still earn 10% a year

    ₩7,140.25

  7. Buy below

    Fair value minus your 25% margin of safety

    ₩5,355.19

Paying ₩144,500.00 instead gives -39.8% a year. Every rule is on the methodology page.

Outcome

What your assumptions give, and the path from today's price.

Fair value

₩7,140.25

Expected return

-39.8% a year

Future price, 2031

₩11,148.50

Buy below

₩5,355.19

Price 1924% above fair valuePrice ₩144,500.00, at your 10% return

Projection

Solid blue: the price at each year end. Dashed blue: from today's price to the 2031 price. Green: from the fair value, rising at your 10% a year to the same end point; buy at or below it and you earn at least that. Every rule is on the methodology page. A model, not a forecast or advice.

Sam Chun Dang Pharm Co. (000250.XKRX) intrinsic value and fair value

The calculator grows one of Sam Chun Dang Pharm Co.'s per-share figures (earnings, free cash flow, revenue, book value or dividends) for a few years, puts an exit multiple on it, and discounts the result back at the yearly return you want. The answers below use its starting inputs for 000250.XKRX; this is analysis, not investment advice.

Frequently asked

What is Sam Chun Dang Pharm Co.'s (000250.XKRX) intrinsic value?+

With Intrinsiqq's starting inputs, Sam Chun Dang Pharm Co.'s fair value is about ₩7,140.25 a share, based on its earnings per share. That assumes earnings per share of ₩523.06 grows about 5.0% a year for 5 years, the stock then trades at 16.7 times earnings, and you want a 10.0% yearly return. On its other figures: revenue ₩138,160.60. Every input can be changed on the page; the result is a model, not a forecast.

Is Sam Chun Dang Pharm Co. overvalued?+

At ₩144,500.00, the price is 1924% above that fair value of ₩7,140.25, and buying at today's price would return about -39.8% a year if those inputs hold. Whether that is cheap or dear depends on whether you believe the growth and the exit multiple, which is what the calculator lets you test. This is analysis from company filings, not investment advice.

What growth does the Sam Chun Dang Pharm Co. valuation assume?+

Earnings per share grows about 5.0% a year to start, a default, because there is too little history. The exit multiple starts at its industry's median.

What is a good margin of safety for Sam Chun Dang Pharm Co.?+

A margin of safety is the cushion you want below the fair value before buying, in case the inputs are wrong. The calculator uses 25%, which puts the buy-below price at ₩5,355.19. Less predictable businesses deserve a wider cushion, or a higher desired return.

How the market compares: US profitability statistics

Held by ETFs

000250.XKRX is in 12 US ETFs. The largest of them, with 000250.XKRX's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing 000250.XKRX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.